https://www.selleckchem.com/products/MLN-2238.html
To explore the effectiveness and safety of conversion surgery after neoadjuvant intraperitoneal-systemic chemotherapy (NIPS) in treating gastric cancer patients with peritoneal metastasis. 80 patients definitely diagnosed with peritoneal metastasis of gastric cancer treated in our hospital from March 2016 to September 2017 were evaluated. All the patients were randomly assigned into two groups and received oral administration of S-1 + intravenous and intraperitoneal chemotherapy with paclitaxel or oral administration of S-1 + intraveno